Literature DB >> 17485263

The role of SHIP in macrophages.

Laura M Sly1, Victor Ho, Frann Antignano, Jens Ruschmann, Melisa Hamilton, Vivian Lam, Michael J Rauh, Gerald Krystal.   

Abstract

The SH2-containing inositol-5'-phosphatase, SHIP, represses the proliferation, survival, and activation of hematopoietic cells, in large part by translocating to membranes following extracellular stimulation and hydrolysing the phosphatidylinositol-3-kinase (PI3K)-generated second messenger PI-3,4,5-P3 (PIP3) to PI-3,4-P2. SHIP-/- mice have, as a result, an increased number of monocyte/macrophages because their progenitors display enhanced survival and proliferation, as well as more rapid differentiation. Interestingly, SHIP-/- mice do not display lipopolysaccharide (LPS)- or CpG oligonucleotide-induced tolerance because this blunting of inflammatory mediator production is contingent upon LPS- and CpG-induced upregulation of SHIP in their macrophages and mast cells. This upregulation is mediated via the production of autocrine-acting TGFbeta which is induced via the MyD88-dependent pathway. The increased levels of SHIP then inhibit both MyD88-dependent and independent signaling. Intriguingly, SHIP-/- peritoneal and alveolar macrophages produce less nitric oxide (NO) than wild-type macrophages because they have constitutively high arginase I levels and this enzyme competes with inducible nitric oxide synthase (iNOS) for the substrate L-arginine. It is likely that, in the face of chronically elevated PIP3 levels in their myeloid progenitors, SHIP-/- mice display a skewed development away from M1 (killer) macrophages towards M2 (healing) macrophages. This suggests that SHIP plays a critical role in programming macrophages.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485263     DOI: 10.2741/2276

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  27 in total

1.  Editorial: switching on arginase in M2 macrophages.

Authors:  Volker Briken; David M Mosser
Journal:  J Leukoc Biol       Date:  2011-11       Impact factor: 4.962

Review 2.  Macrophage polarization: the link between inflammation and related diseases.

Authors:  Samina Bashir; Yadhu Sharma; Asif Elahi; Farah Khan
Journal:  Inflamm Res       Date:  2016-01       Impact factor: 4.575

3.  A key role for the phosphorylation of Ser440 by the cyclic AMP-dependent protein kinase in regulating the activity of the Src homology 2 domain-containing Inositol 5'-phosphatase (SHIP1).

Authors:  Jun Zhang; Kodi S Ravichandran; James C Garrison
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

4.  SHIP-deficient mice develop spontaneous intestinal inflammation and arginase-dependent fibrosis.

Authors:  Keith W McLarren; Alexandra E Cole; Shelley B Weisser; Nicole S Voglmaier; Victoria S Conlin; Kevan Jacobson; Oana Popescu; Jean-Luc Boucher; Laura M Sly
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

5.  G-CSF improves murine G6PC3-deficient neutrophil function by modulating apoptosis and energy homeostasis.

Authors:  Hyun Sik Jun; Young Mok Lee; Ki Duk Song; Brian C Mansfield; Janice Y Chou
Journal:  Blood       Date:  2011-02-03       Impact factor: 22.113

6.  IBD 2009: emerging research frontiers on the path to a cure.

Authors:  A Hillary Steinhart; G Tolomiczenko
Journal:  Can J Gastroenterol       Date:  2010-09       Impact factor: 3.522

7.  MicroRNA 155 regulates Japanese encephalitis virus-induced inflammatory response by targeting Src homology 2-containing inositol phosphatase 1.

Authors:  Menaka Chanu Thounaojam; Kiran Kundu; Deepak Kumar Kaushik; Shalini Swaroop; Anita Mahadevan; Susarla Krishna Shankar; Anirban Basu
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 8.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

9.  Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.

Authors:  Jun Zhang; Scott F Walk; Kodi S Ravichandran; James C Garrison
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

10.  The inositol phosphatase SHIP controls Salmonella enterica serovar Typhimurium infection in vivo.

Authors:  Jennifer L Bishop; Laura M Sly; Gerald Krystal; B Brett Finlay
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.